Blue Nevi

Back

Background

Two clinically recognized variants of blue nevus exist: the common blue nevus and the cellular blue nevus.

Tièche, a student of Jadassohn, first described the common blue nevus in 1906. Earlier authors described similar lesions as chromatophoroma and melanofibroma. The common blue nevus is a flat to slightly elevated, smooth surfaced macule, papule, or plaque that is gray-blue to bluish black in color. Lesions are usually solitary and found on the head and the neck, the sacral region, and the dorsal aspects of the hands and feet.

The cellular blue nevus was first described as a variant of melanoma. Later, it was classified as a variant of blue nevus. Controversy still arises over the precise distinction of atypical cellular blue nevus from melanoma.[1] The cellular blue nevus is a less common lesion but often clinically similar to the common blue nevus. These lesions tend to be large, usually measuring 1-3 cm in diameter. Lesions are elevated, smooth-surfaced papules or plaques that are gray-blue to bluish black in color. Lesions are usually solitary and found on the buttocks, the sacral region, and occasionally on the dorsal aspects of the hands and the feet.

In addition to the common blue nevus and the cellular blue nevus, there are variants similar to typical nevi, such as the combined blue nevus, the sclerosing (desmoplastic) blue nevus, the amelanotic blue nevus, and the epitheliod blue nevus.[2]

Pathophysiology

Although definitive experimental evidence is lacking, blue nevi are believed to represent dermal arrest in embryonal migration of neural crest melanocytes that fail to reach the epidermis. Collections of melanocytes can be found in fetal dermis, but they involute during later gestation.

Because of the variation of blue nevi in different populations, a genetic predisposition has been suggested. However, familial cases of blue nevi are exceedingly rare.

The clinically noted blue color is due to the depth of melanin in the epidermis and the Tyndall effect. The Tyndall effect is the preferential absorption of long wavelengths of light by melanin and the scattering of shorter wavelengths, representing the blue end of the spectrum, by collagen bundles.

Common blue nevi show fewer BRAF mutations compared with congenital and acquired nevi,[3] but they show somatic mutations in the heterotrimeric G protein α-subunit, GNAQ, in up to 83% of cases.[4, 5]

Etiology

See Pathophysiology. Although blue nevi are most frequently seen on the skin, they have also been reported in the oral cavity, subungually,[7] in lymph nodes, and in organs such as the brain, pulmonary tract, and prostate.

Epidemiology

Frequency

United States

Blue nevi are most frequently noted in Asian populations, where the prevalence is estimated to be 3-5% in adults. They are found in 1-2% of white adults and are rarely found in blacks. Blue nevi are uncommon at birth or in the first few years of life, with an estimated prevalence of less than 1 case per 1000 population.

International

The international incidence of blue nevi varies with the population examined.

Sex

Blue nevi are twice as common in women than in men.

Age

Blue nevi may develop at any age but are usually noticed in the second decade of life or later.

Prognosis

The prognosis of blue nevi is excellent. Most cases remain entirely benign. Blue nevi usually persist unchanged throughout life and are asymptomatic. Rare cases of malignant melanoma have been reported arising in association with cellular blue nevi.[6]

History

Once a blue nevus appears, it tends to remain unchanged throughout life. Occasionally, common blue nevi flatten and fade in color. These changes are evenly distributed throughout the lesion.

Malignant change in cellular blue nevi may be heralded by a sudden increase in size and occasionally ulceration.

Cases of eruptive blue nevi have been reported, some following skin trauma, such as sunburn.

Physical Examination

Blue nevi are usually smooth-surfaced, dome-shaped papules that slowly develop from a macule to a papule.[8]

Common blue nevi tend to be smaller than 1 cm, and cellular blue nevi tend to be larger than 1 cm.

Blue nevi are most commonly found on the skin. Rare cases of common blue nevi have been reported in the vagina, the spermatic cord, the uterine cervix, the lymph node, the prostate, the oral mucosa, and the bronchus.[9]

See the images below.



View Image

Common blue nevus on the scalp.



View Image

Common blue nevus on the hand.

Complications

Common blue nevi are clinically benign. Lesions tend to persist unchanged throughout life.

Cellular blue nevi are usually clinically benign. Because of their large size, biopsy and excision tend to be performed more often on cellular blue nevi than on common blue nevi.

Rare cases of malignant melanoma have been reported to arise in cellular blue nevi. Any change in these lesions is an indication for biopsy or excision.

Laboratory Studies

Laboratory studies are not necessary.

Imaging Studies

Imaging studies generally are not necessary; however, dermoscopy is a useful method for separating common blue nevi from a melanoma. The classic dermatoscopic features include a homogeneous steel-blue color with no pigment network, no aggregated globules, and no branched streaks,[18, 19, 20] although variations, including blue globules and dots and pigmented networks, have been reported.[21]

Histologic Findings

A histologic continuum exists from common blue nevi to cellular blue nevi.

In common blue nevus, a vaguely nodular collection of poorly melanized spindled melanocytes and deeply pigmented dendritic melanocytes within thickened collagen bundles is seen. Scattered melanophages are usually noted. No mitoses are present.



View Image

Common blue nevus. Numerous elongated dendritic melanocytes with a subepidermal grenz zone. Courtesy of Rose Elenitsas, MD.

In cellular blue nevus, a well-demarcated nodule formed by fascicles and nests of tightly packed, moderately sized, spindled to oval melanocytes with scattered melanophages is seen. The lesion is centered in the reticular dermis; blunt-ended, bulbus extensions that extend into the subcutaneous fat may be noted. Occasional mitoses may be present, but significant cytologic atypia and areas of necrosis are absent. Often, a component of common blue nevus is seen within these lesions.



View Image

Cellular blue nevus. Deep proliferation of dendritic melanocytes, broader at the surface than the base, with islands of paler cells with larger nuclei....

A number of variants of blue nevi with corresponding histologic changes have been described, including epithelioid blue nevus (classic description is with the Carney complex, but also is seen without this condition), atypical blue nevus, deep penetrating blue nevus, sclerosing blue nevus, and amelanotic blue nevus.[22, 23]

The term malignant blue nevus is synonymous with malignant melanoma arising in association with a cellular blue nevus or growing in a histologic pattern similar to that of a cellular blue nevus. These lesions typically have a pronounced cytologic atypia, hyperchromasia, necrosis, an increased mitotic rate, and an infiltrative growth pattern.[24] Complete excision with a margin of healthy skin according to National Comprehensive Cancer Network (NCCN) guidelines should be performed.

Medical Care

No medical therapy is available.

Surgical Care

A biopsy should be performed on any changing pigmented lesion. For a solitary lesion, simple excision is usually curative. Rare cases of persistent blue nevi, manifesting as satellite lesions around the original excision site, have been reported. These must be distinguished from malignant blue nevus, and reexcision is recommended.

Consultations

Clinical experience with pigmented lesions is necessary to determine the proper diagnosis. Persons with unusual or many lesions may benefit from consultation with a dermatologist.

What are blue nevi?What is the pathophysiology of blue nevi?Where are blue nevi most frequently located?What is the prevalence of blue nevi in the US?What is the global prevalence of blue nevi?What are the sexual predilections of blue nevi?Which age groups have the highest prevalence of blue nevi?What is the prognosis of blue nevi?Which clinical history findings are characteristic of blue nevi?Which physical findings are characteristic of blue nevi?What are the possible complications of blue nevi?Which conditions are included in the differential diagnoses of blue nevi?What are the differential diagnoses for Blue Nevi?What is the role of lab testing in the workup of blue nevi?What is the role of imaging studies in the workup of blue nevi?Which histologic findings are characteristic of blue nevi?How are blue nevi treated?When is biopsy of a blue nevi indicated?Which specialist consultations are beneficial to patients with blue nevi?

Author

Rudolf R Roth, MD, Medical Director, Department of Dermatology, Penn Medicine at Radnor; Associate Professor of Clinical Dermatology, Department of Dermatology, University of Pennsylvania School of Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

Scott M Acker, MD, Associate Professor, Director of Dermatopathology, Departments of Dermatology and Pathology, University of Alabama at Birmingham

Disclosure: Nothing to disclose.

Specialty Editors

Michael J Wells, MD, FAAD, Dermatologic/Mohs Surgeon, The Surgery Center at Plano Dermatology

Disclosure: Nothing to disclose.

Lester F Libow, MD, Dermatopathologist, South Texas Dermatopathology Laboratory

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD, Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

Disclosure: Received income in an amount equal to or greater than $250 from: Elsevier; WebMD.

References

  1. Phadke PA, Zembowicz A. Blue nevi and related tumors. Clin Lab Med. 2011 Jun. 31(2):345-58. [View Abstract]
  2. Zembowicz A, Phadke PA. Blue nevi and variants: an update. Arch Pathol Lab Med. 2011 Mar. 135 (3):327-36. [View Abstract]
  3. Gill M, Celebi JT. B-RAF and melanocytic neoplasia. J Am Acad Dermatol. 2005 Jul. 53(1):108-14. [View Abstract]
  4. Van Raamsdonk CD, Bezrookove V, Green G, Bauer J, Gaugler L, O'Brien JM, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009 Jan 29. 457 (7229):599-602. [View Abstract]
  5. Emley A, Nguyen LP, Yang S, Mahalingam M. Somatic mutations in GNAQ in amelanotic/hypomelanotic blue nevi. Hum Pathol. 2011 Jan. 42(1):136-40. [View Abstract]
  6. Lambert WC, Brodkin RH. Nodal and subcutaneous cellular blue nevi. A pseudometastasizing pseudomelanoma. Arch Dermatol. 1984 Mar. 120(3):367-70. [View Abstract]
  7. Causeret AS, Skowron F, Viallard AM, Balme B, Thomas L. Subungual blue nevus. J Am Acad Dermatol. 2003 Aug. 49(2):310-2. [View Abstract]
  8. Di Cesare A, Sera F, Gulia A, Coletti G, Micantonio T, Fargnoli MC, et al. The spectrum of dermatoscopic patterns in blue nevi. J Am Acad Dermatol. 2011 Oct 24. [View Abstract]
  9. Dailey VL, Hameed O. Blue nevus of the prostate. Arch Pathol Lab Med. 2011 Jun. 135(6):799-802. [View Abstract]
  10. Cooper PH. Deep penetrating (plexiform spindle cell) nevus. A frequent participant in combined nevus. J Cutan Pathol. 1992 Jun. 19(3):172-80. [View Abstract]
  11. Munoz C, Quintero A, Sanchez JL, Ruiz-Santiago H. Persistent blue nevus simulating melanoma. J Am Acad Dermatol. 2004 May. 50(5 Suppl):S118-20. [View Abstract]
  12. Carney JA. Psammomatous melanotic schwannoma. A distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol. 1990 Mar. 14(3):206-22. [View Abstract]
  13. Carney JA, Ferreiro JA. The epithelioid blue nevus. A multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol. 1996 Mar. 20(3):259-72. [View Abstract]
  14. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore). 1985 Jul. 64(4):270-83. [View Abstract]
  15. Carney JA, Headington JT, Su WP. Cutaneous myxomas. A major component of the complex of myxomas, spotty pigmentation, and endocrine overactivity. Arch Dermatol. 1986 Jul. 122(7):790-8. [View Abstract]
  16. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum Mol Genet. 2000 Dec 12. 9 (20):3037-46. [View Abstract]
  17. Blackford S, Roberts DL. Familial multiple blue naevi. Clin Exp Dermatol. 1991 Jul. 16(4):308-9. [View Abstract]
  18. Braun RP, Rabinovitz HS, Oliviero M, Kopf AW, Saurat JH. Dermoscopy of pigmented skin lesions. J Am Acad Dermatol. 2005 Jan. 52(1):109-21. [View Abstract]
  19. Ferrara G, Soyer HP, Malvehy J, et al. The many faces of blue nevus: a clinicopathologic study. J Cutan Pathol. 2007 Jul. 34(7):543-51. [View Abstract]
  20. Di Cesare A, Sera F, Gulia A, Coletti G, Micantonio T, Fargnoli MC, et al. The spectrum of dermatoscopic patterns in blue nevi. J Am Acad Dermatol. 2012 Aug. 67 (2):199-205. [View Abstract]
  21. Tsunemi Y, Saeki H, Tamaki K. Blue naevus with pigment network-like structure on dermoscopy. Acta Derm Venereol. 2008. 88(4):412-3. [View Abstract]
  22. Barnhill RL, Barnhill MA, Berwick M, Mihm MC Jr. The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum Pathol. 1991 Jan. 22(1):52-8. [View Abstract]
  23. Moreno C, Requena L, Kutzner H, de la Cruz A, Jaqueti G, Yus ES. Epithelioid blue nevus: a rare variant of blue nevus not always associated with the Carney complex. J Cutan Pathol. 2000 May. 27(5):218-23. [View Abstract]
  24. Loghavi S, Curry JL, Torres-Cabala CA, Ivan D, Patel KP, Mehrotra M, et al. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature. Mod Pathol. 2014 Nov. 27 (11):1468-78. [View Abstract]
  25. Maize JC, LeBoit PE, Metcalf JS, et al. Neoplasms of melanocytes. Maize J, Burgdorf WHC, Hurt MA, et al, eds. Cutaneous Pathology. Philadelphia, Pa: Churchill Livingstone; 1998. 677-82.
  26. Novice FM, Collison DW, Burgdorf WHC, et al. Disorders of hyperpigmentation. Novice FM, Collison DW, eds. Handbook of Genetic Skin Disorders. 1st ed. Philadelphia, Pa: WB Saunders; 1994. 195-8.
  27. Rhodes AR. Benign neoplasias and hyperplasias of melanocytes. Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999. 1037-43.

Common blue nevus on the scalp.

Common blue nevus on the hand.

Common blue nevus. Numerous elongated dendritic melanocytes with a subepidermal grenz zone. Courtesy of Rose Elenitsas, MD.

Cellular blue nevus. Deep proliferation of dendritic melanocytes, broader at the surface than the base, with islands of paler cells with larger nuclei. Courtesy of Rose Elenitsas, MD.

Common blue nevus on the scalp.

Common blue nevus on the hand.

Common blue nevus. Numerous elongated dendritic melanocytes with a subepidermal grenz zone. Courtesy of Rose Elenitsas, MD.

Cellular blue nevus. Deep proliferation of dendritic melanocytes, broader at the surface than the base, with islands of paler cells with larger nuclei. Courtesy of Rose Elenitsas, MD.